A vaccine is now available to help prevent four types of HPV. These include types 6 and 11, which are two ‘low-risk’ types responsible for an estimated 90 per cent of genital warts, and types 16 and 18, ‘high-risk’ types responsible for an estimated 70 per cent of cervical cancers.
The HPV vaccine currently approved is called Gardasil®. It can be given to girls and young women ages nine to 26 years. This vaccine is currently not availble for males, although there are studies being completed to determine effectiveness of the vaccine on this population.
The vaccine requires three shots. The second shot is given two months after the first dose, and the third is given six months after the first dose. The complete series should be given within 12 months. It is not known at this time if there will need to be a booster in the future.
Although the vaccine is currently only public-funded for girls in grade 8, the vaccine is available through health care providers for approximately $400. Some insurance companies provide coverage for this vaccine. To determine if this vaccine is covered by your health care plan, contact your provider and provide them with the product DIN : 02283190.
